Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul F Robbins

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Cancer Journal (Sudbury, Mass.)|November 21, 2015
T-Cell Receptor-Transduced T Cells: Clinical ExperiencePaul F Robbins
Journal of Immunology (Baltimore, Md. : 1950)|February 19, 2013
Helping tumor cells to diePaul F Robbins
Cancer Journal (Sudbury, Mass.)|April 15, 2017
Tumor-Infiltrating Lymphocyte Therapy and NeoantigensPaul F Robbins
Journal of Leukocyte Biology|February 22, 2007
Contrasting effects of FLIPL overexpression in human T cells on activation-induced cell death and cytokine productionJehad Charo, Paul F Robbins
Seminars in Immunology|December 15, 2015
Cancer immunotherapy targeting neoantigensYong-Chen Lu, Paul F Robbins
International Immunology|May 22, 2016
Targeting neoantigens for cancer immunotherapyYong-Chen Lu, Paul F Robbins
The New England Journal of Medicine|February 16, 2017
T-Cell Transfer Therapy Targeting Mutant KRASSteven A Rosenberg, Eric Tran, Paul F Robbins
Nature Immunology|February 16, 2017
'Final common pathway' of human cancer immunotherapy: targeting random somatic mutationsEric Tran, Paul F Robbins, Steven A Rosenberg
Cancer Cell|April 10, 2023
Adoptive cell transfer immunotherapy for patients with solid epithelial cancersSteven A Rosenberg, Maria R Parkhurst, Paul F Robbins
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 23, 2004
Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapyJuhua Zhou, Mark E Dudley, Steven A Rosenberg, et al.
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Cancer Journal (Sudbury, Mass.)|November 21, 2015
T-Cell Receptor-Transduced T Cells: Clinical ExperiencePaul F Robbins
Journal of Immunology (Baltimore, Md. : 1950)|February 19, 2013
Helping tumor cells to diePaul F Robbins
Cancer Journal (Sudbury, Mass.)|April 15, 2017
Tumor-Infiltrating Lymphocyte Therapy and NeoantigensPaul F Robbins
Journal of Leukocyte Biology|February 22, 2007
Contrasting effects of FLIPL overexpression in human T cells on activation-induced cell death and cytokine productionJehad Charo, Paul F Robbins
Seminars in Immunology|December 15, 2015
Cancer immunotherapy targeting neoantigensYong-Chen Lu, Paul F Robbins
International Immunology|May 22, 2016
Targeting neoantigens for cancer immunotherapyYong-Chen Lu, Paul F Robbins
The New England Journal of Medicine|February 16, 2017
T-Cell Transfer Therapy Targeting Mutant KRASSteven A Rosenberg, Eric Tran, Paul F Robbins
Nature Immunology|February 16, 2017
'Final common pathway' of human cancer immunotherapy: targeting random somatic mutationsEric Tran, Paul F Robbins, Steven A Rosenberg
Cancer Cell|April 10, 2023
Adoptive cell transfer immunotherapy for patients with solid epithelial cancersSteven A Rosenberg, Maria R Parkhurst, Paul F Robbins
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 23, 2004
Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapyJuhua Zhou, Mark E Dudley, Steven A Rosenberg, et al.
Pageof 13